In lung cancer cells, KDM5A binds directly to the promoter regions of cyclin D1 and cyclin-dependent kinase inhibitor p27 (KIP1) and promotes G1-S progression by activating cyclins D1 and E1 and suppressing p27 (CDKN1B) [40]. Here, KDM5A is linked to lung carcinoma.